comparemela.com

Latest Breaking News On - Vp research development - Page 2 : comparemela.com

Mustang Survival President Jason Leggatt Resigns

Mustang Survival President Announces Resignation

Jason Leggatt, president of Mustang Survival and Andrew Branagh, the CEO of The Wing Group, announced that Leggatt had resigned from his position. He will remain with the company as a member of its Board.

United-kingdom
British
Juanita-killen
Life-jacket-association
Fabtek-industries
Wing-group-mustang-survival
University-of-british-columbia
Swing-group
Vp-research-development
Business-development
Patten-company
Mustang-survival

Inolex grows preservation patents portfolio

Inolex grows preservation patents portfolio
cosmeticsbusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cosmeticsbusiness.com Daily Mail and Mail on Sunday newspapers.

China
Chinese
Michaelj-fevola
Julia-wray
Vp-research-development
Chinese-patent

Blaize Delivers First Open and Code-free AI Software Platform Spanning the Entire Edge AI Application Lifecycle

Industry Articles Transforms productivity for faster ROI of AI edge deployments El DORADO HILLS, CA December 14, 2020 Blaize today fully unveiled the Blaize AI Studio offering, the industry’s first open and code-free software platform to span the complete edge AI operational workflow from idea to development, deployment and management. AI Studio dramatically reduces edge AI application deployment complexity, time, and cost by breaking the barriers within existing application development and machine learning operations (MLOps) infrastructure that hinder edge AI deployments. Eliminating the complexities of integrating disparate tools and workflows, along with the introduction of multiple ease-of-use and intelligence features, AI Studio reduces from months to days the time required to go from models to deployed production applications.

Cambridge
Cambridgeshire
United-kingdom
Dmitry-zakharchenko
Dinakar-munagala
Tim-ensor
Mlops-devops
Data-center
Capgemini-group
Vp-research-development
Transfer-learning
Early-adopter-customers

Immunovia to Host a Third Webinar in the Series on IMMray PanCan-d: Verification Study and Clinical Use

(1) LUND, Sweden, Dec. 11, 2020 /PRNewswire/ Immunovia AB (publ) ( Immunovia ), a near-commercial stage diagnostics company developing ground-breaking antibody-based multiplex microarray technology platform called IMMray for the early detection of cancer, today announced that the company will be hosting the third webinar in the series on IMMray PanCan-d, Immunovia s test for early detection of pancreatic cancer. This third webinar will cover IMMray PanCan-d verification study results and its clinical use including feedback from experts in pancreatic cancer and pancreatic diseases. Event Details: Webinar No. 3: Immunovia s IMMray PanCan-d Webinar Series Verification Study and Clinical Use Date and Time: December 17, 2020 at 15:00 CET Moderator for the Webinar is CEO Patrik Dahlen

Sweden
United-states
Stockholm
Massachusetts
Immunovia-immray
Immunovia-immray-pancand-webinar
Laura-chirica
Immray-pancan-d
Linda-mellby
Patrik-dahlen
Thomas-king
School-of-health-professions

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.